🔎 Trials Near Me

Akèy › Obèsite › Kentucky › Lexington

Etid klinik pou Obèsite nan Lexington, KY

10 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Lexington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
  • AMR Clinical - Lexington, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • AMR Clinical, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • The Research Group of Lexington LLC, Lexington
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Ap rekriteFaz 3
  • The Alliance for Multispecialty Research LLC AMR, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07745504

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

Ap rekriteFaz 4Volontè an sante akeyi
  • University of Kentucky, Lexington
Laj 35 a 65 · Tout sèks · Mizajou Aug 31, 2026 · NCT05051436

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • The Research Group of Lexington LLC, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Cannabis for Obesity Trial

Ap rekriteFaz 2Volontè an sante akeyi
  • University of Kentucky, Lexington
Laj 18 a 65 · Tout sèks · Mizajou Aug 7, 2026 · NCT06137365

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

Ap rekriteEtid obsèvasyon
  • University of Kentucky, Lexington
Laj 12 a 17 · Tout sèks · Mizajou Jul 21, 2026 · NCT06967389

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

Ap rekriteFaz 1
  • MBX Biosciences Investigational Site, Lexington
Laj 18 a 65 · Tout sèks · Mizajou Jun 9, 2026 · NCT07142707

2024 Tirzepatide-Bariatric Surgery

Ap rekriteFaz 4
  • University of Kentucky, Lexington
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT06721507

Etid Obèsite nan lòt vil

Lòt etid nan Lexington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.